Guidelines International Network (GIN)
Powered by EBSCO

Guidelines International Network

3371 - 3380 of 3645 results found

Unipolare Depression – Nationale VersorgungsLeitlinie (NVL)

MeSH Terms

Depressive Disorder (F03.600.300); Behavioral Symptoms (F01.145.126); Mood Disorders (F03.600)

Guideline Contact
Corinna Schaefer ([email protected])
English Title Translation
Unipolar depression – German National Disease Management Guideline
Date for Review
2029-09-27
Publication Scope
assessment
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
English
German
Authors
AQuMed/AEZQ (DE)
Publication Year
2022

Unipolare Depression. PatientenLeitlinie zur Nationalen VersorgungsLeitlinie

MeSH Terms
Behavior and Behavior Mechanisms (F01); Behavior (F01.145); Mental Disorders (F03); Mood Disorders (F03.600); Depressive Disorder (F03.600.300)
Guideline Contact
Corinna Schaefer ([email protected])
English Title Translation
Unipolar depression – patient version of the German S3-Guideline/National Disease Management Guideline
Date for Review
2001-11-20
Publication Scope
assessment
management
Countries of Application
Germany
Guideline Publication Status
Published
Languages
German
Authors
AQuMed/AEZQ (DE)
Publication Year
2016

Univentrikuläres Herz im Kindes- und Jugendalter. S2k-LL (DGPK)

MeSH Terms

Heart (A07.541); Cardiovascular System (A07); Cardiovascular Surgical Procedures (E04.100); Cardiovascular Abnormalities (C14.240); Cardiovascular Abnormalities (C16.131.240)

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Univentricular heart in childhood and adolescence
Expected Publication Date
31/12/2025
Publication Scope
assessment
management
Countries of Application
Germany
Languages
German
Authors
AWMF (DE)

Unruptierte intrakranielle Aneurysmen. S3-LL (DGN)

MeSH Terms

Intracranial Aneurysm (C14.907.253.560.300); Intracranial Aneurysm (C10.228.140.300.510.600); Intracranial Aneurysm (C14.907.055.635)

Guideline Contact
Ina Kopp ([email protected])
English Title Translation
Undisruptive intracranial aneurysms
Expected Publication Date
30/09/2025
Publication Scope
assessment
management
Countries of Application
Germany
Guideline Publication Status
Development
Languages
German
Authors
AWMF (DE)

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors

MeSH Terms

Adenocarcinoma of Lung (C04.557.470.200.025.022); Carcinoma, Non-Small-Cell Lung (C04.588.894.797.520.109.220.249); Lung neoplasms (C04.588.894.797.520); Carcinoma, Bronchogenic (C04.588.894.797.520.109.220); "Genes, erbB-1" (G05.360.340.024.340.375.500.791.295.300); "ErbB Receptors" (D08.811.913.696.620.682.725.400.009); "Proto-Oncogene proteins p21(ras)" (D08.811.277.040.330.300.400.500.600); "Anaplastic lymphoma kinase” (D08.811.913.696.620.682.725.400.002); "Proto-oncogene proteins" (D12.776.624.664.700); "Proto-oncogene proteins B-raf" (D08.811.913.696.620.682.700.559.842.374); "Receptor, trkA" (D08.811.913.696.620.682.725.400.660); "Receptor, trkB" (D08.811.913.696.620.682.725.400.700); "Receptor, trkC" (D08.811.913.696.620.682.725.400.800); "Proto-oncogene proteins c-met" (D08.811.913.696.620.682.725.400.075); "Proto-oncogene proteins c-ret" (D08.811.913.696.620.682.725.400.087); Receptor, ErbB-2 (D08.811.913.696.620.682.725.400.009.400); Proto-oncogene proteins c-akt (D08.811.913.696.620.682.700.755); Discoidin Domain Receptor 2 (D08.811.913.696.620.682.725.400.005.750); Receptor, Fibroblast growth factor, type 1 (D08.811.913.696.620.682.725.400.177); Receptor, Fibroblast growth factor, type 2 (D08.811.913.696.620.682.725.400.178); Receptor, Fibroblast growth factor, type 3 (D08.811.913.696.620.682.725.400.179); Receptor, Fibroblast growth factor, type 4 (D08.811.913.696.620.682.725.400.180); "Kelch-like ECH-associated protein 1" (D12.644.360.024.306); "MAP Kinase Kinase 1" (D08.811.913.696.620.682.700.565.100); Neuregulin-1 (D12.644.276.860.550.750); Class I Phosphatidylinositol 3-Kinases (D08.811.913.696.620.500.100.100); Tumor suppressor protein p53 (D12.776.157.687.650)

Guideline Contact
Christina Ventura ([email protected])
Keywords
tki, molecular testing, treatment, lung cancer patients, targeted tyrosine kinase inhibitors, cap, college of american pathologists, international association for the study of lung cancer, association for molecular pathology, guideline update, evidence-based guideline, clinical molecular testing of non-small cell lung cancers, nsclc
Publication Date
Original Published: June 2013 Update Published: January 22, 2018
Expected Publication Date
Update: Q4, 2025
Publication Scope
assessment
Countries of Application
United States
Guideline Publication Status
Development
Languages
English
Authors
CAP (US)
Publication Year
2018